PRKAA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.462200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.350600E-01
Normal-vs-Stage2
7.242600E-01
Normal-vs-Stage3
3.598600E-01
Normal-vs-Stage4
2.888800E-01
Stage1-vs-Stage2
5.484000E-01
Stage1-vs-Stage3
1.145840E-01
Stage1-vs-Stage4
3.745600E-01
Stage2-vs-Stage3
1.535850E-01
Stage2-vs-Stage4
5.268300E-02
Stage3-vs-Stage4
1.142390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.855200E-01
Normal-vs-AfricanAmerican
6.069600E-01
Normal-vs-Asian
6.946000E-01
Caucasian-vs-AfricanAmerican
7.008000E-01
Caucasian-vs-Asian
8.179400E-01
AfricanAmerican-vs-Asian
8.569600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.890800E-01
Normal-vs-Female
6.957600E-01
Male-vs-Female
6.890600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.381800E-01
Normal-vs-Age(41-60Yrs)
4.838600E-01
Normal-vs-Age(61-80Yrs)
8.521000E-01
Normal-vs-Age(81-100Yrs)
8.996000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.878800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.396800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.135400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.189990E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.872000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.680400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.601800E-01
Normal-vs-Daily Drinker
9.261800E-01
Normal-vs-Weekly Drinker
8.842800E-01
Normal-vs-Occasional Drinker
4.779800E-01
Normal-vs-Social Drinker
8.911400E-01
Non Drinker-vs-Daily Drinker
5.842200E-01
Non Drinker-vs-Weekly Drinker
9.239400E-01
Non Drinker-vs-Occasional Drinker
1.887610E-01
Non Drinker-vs-Social Drinker
9.337600E-01
Daily Drinker-vs-Weekly Drinker
6.589200E-01
Daily Drinker-vs-Occasional Drinker
1.357390E-01
Daily Drinker-vs-Social Drinker
7.016000E-01
Weekly Drinker-vs-Occasional Drinker
4.618400E-01
Weekly Drinker-vs-Social Drinker
8.884400E-01
Occasional Drinker-vs-Social Drinker
2.448800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.560800E-01
Normal-vs-Grade 2
1.034760E-01
Normal-vs-Grade 3
1.624240E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.977800E-01
Grade 1-vs-Grade 3
3.581400E-01
Grade 1-vs-Grade 4
3.560800E-01
Grade 2-vs-Grade 3
8.336600E-01
Grade 2-vs-Grade 4
1.034760E-01
Grade 3-vs-Grade 4
1.624240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.636600E-01
Normal-vs-NonDiabetic
7.682400E-01
Diabetic-vs-NonDiabetic
3.054200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.760200E-01
Normal-vs-NoPancreatitis
8.076400E-01
Pancreatitis-vs-NoPancreatitis
6.023200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.331400E-01
Normal-vs-N1
7.332200E-01
N0-vs-N1
9.958800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.835000E-01
Normal-vs-TP53-NonMutant
7.281800E-01
TP53-Mutant-vs-TP53-NonMutant
1.052350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
